Merck Sharp & Dohme LLC v. Halozyme, Inc. et al.

PGR2025-00006

Petition for post‑grant review of U.S. Patent No. 12152262 filed by Merck Sharp & Dohme LLC against Halozyme, Inc.

Jurisdiction
US PTAB
Case Number
PGR2025-00006
Decision Date
12 October 2024
Filing Date
12 October 2024

Detailed Summary

Merck Sharp & Dohme LLC has filed a Corrected Petition for Post‑Grant Review (PGR) challenging U.S. Patent No. 12152262 owned by Halozyme, Inc. The docket lists the parties, counsel, and the petition identifier (PGR2025-00006) but provides no substantive claim or prior‑art details. The proceeding is currently at the petition stage with no institution decision or outcome reported.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Merck Sharp & Dohme LLC vs Halozyme, Inc. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentPGR2026-00001

Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.

The PTAB held that all 20 claims of Netlist’s ’160 memory‑package patent are obvious over the combined teachings of Kim, Rajan, and Wyman, rendering them unpatentable. Samsung and its Micron co‑petitioners prevailed.

patentIPR2025-00242

Precision Cancer Technologies Inc.vsOncoustics Inc.

Precision Cancer Technologies Inc.'s IPR challenge against Oncoustics Inc. was denied by the PTAB, failing to meet the reasonable likelihood of prevailing standard. The Board found Petitioner failed to sufficiently demonstrate that prior art processed a 'single static set' of raw RF ultrasound data.

patentIPR2025-01398

CrowdStrike, Inc. et al.vsSkysong Innovations, LLC

CrowdStrike has filed a petition for inter partes review of Skysong Innovations’ U.S. Patent 11,275,900, asserting that all 14 claims are obvious over a suite of prior‑art references covering machine‑learning‑based cyber‑threat classification.

patentIPR2025-00728

Imperative Care, Inc.vsInari Medical, Inc. et al.

The PTAB has instituted inter partes review on all 15 claims of Inari Medical’s embolism‑treatment patent after finding Imperative Care’s obviousness arguments sufficiently persuasive.

patentIPR2025-01395

TOP GLORY TRADING GROUP INC. et al.vsCole Haan LLC et al.

Exhibit 2002 is a settlement agreement in IPR2025-01395 between Top Glory Trading Group Inc., DP Dream Pairs, Inc., and Cole Haan LLC concerning U.S. Patent No. 768969. The parties resolved the dispute, terminating the proceeding.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call